DT&CRO CO., Ltd. (KOSDAQ:383930)
South Korea · Delayed Price · Currency is KRW 1,848.00
+9.00 (0.49%)
At close: Aug 11, 2026
DT&CRO CO. Market Cap
DT&CRO CO. has a market cap or net worth of 23.63 billion as of August 11, 2026. Its market cap has decreased by -42.07% in one year.
Market Cap
23.63B
Enterprise Value
59.08B
Revenue
47.77B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,848.00
ChartMarket Cap Chart
Since November 11, 2022, DT&CRO CO.'s market cap has decreased from 87.47B to 23.63B, a decrease of -72.99%. That is a compound annual growth rate of -29.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 23.63B | -28.65% |
| Dec 30, 2025 | 33.11B | -55.30% |
| Dec 30, 2024 | 74.07B | -67.91% |
| Dec 28, 2023 | 230.80B | 305.63% |
| Dec 29, 2022 | 56.90B | -34.95% |
| Nov 11, 2022 | 87.47B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 211.93B |
| DreamCIS | 83.40B |
| P&K Skin Research Center | 52.33B |
| Kolmar BioTech | 39.30B |
| HLB bioStep | 35.80B |
| SLS BIO | 26.89B |
| C&R Research | 21.79B |
| Curachem | 12.65B |